Brief – Others 2026-06-14
Worth Noting
A cellular reprogramming therapy has been given to a human for the first time in a landmark clinical trial. World-first: therapy to make cells young again given to a person The trial aims to rejuvenate aging cells through partial reprogramming, a technique that has shown dramatic results in animal studies. Whether it translates safely to humans is the central question; this first participant makes that test real.
NOAA has officially declared El Niño, and scientists warn it could push 2026 to a new global temperature record. El Niño is here and could tip Earth to a new record hot year El Niño layers additional warming on top of a baseline already elevated by climate change, threatening to intensify floods and heat waves across multiple continents while potentially suppressing Atlantic hurricane activity.
New analysis suggests permafrost may be hiding far more carbon than current models account for — “deep carbon” that could substantially accelerate warming once released. Earth’s permafrost could soon release hidden ‘deep carbon,’ supercharging warming If the finding holds up, it means existing climate projections may be systematically underestimating a key feedback loop, with limited ability to intervene once the thaw passes critical thresholds.
Moderna and others are racing to develop an mRNA vaccine against the Bundibugyo strain of Ebola driving the current outbreak in Central Africa. Inside the race to develop a new Ebola vaccine Unlike the well-studied Zaire strain, Bundibugyo has no approved vaccine or treatment, and the outbreak is widening — making this one of the more urgent global health development stories of the year.
More than 100 planned U.S. wind farms across 21 states are stalled after the Pentagon indefinitely delayed routine military airspace reviews, prompting a lawsuit. Renewable Groups Sue to End Pentagon’s ‘Total Halt’ of Wind Power The reviews were historically a formality; their suspension amounts to a de facto moratorium on new wind capacity at a moment when U.S. grid demand is rising sharply.
World Cup Watch
Folarin Balogun’s two-goal performance against Paraguay answered a long-standing question about the USMNT’s striking options. England’s loss is USA’s gain as Pochettino finds a spearhead in Folarin Balogun The Monaco striker combined clinical finishing with intelligent channel running, giving Pochettino a genuine focal point the team has lacked for years. The 4-1 scoreline flattered the margin, but Balogun’s movement repeatedly exposed Paraguay’s high defensive line in ways that should concern stronger opponents.
Brazil drew with Morocco 1-1, raising more questions than their Vinicius Jr. wonder goal answered. Has Vinicius Jr brilliance just papered over the Brazilian cracks? Morocco’s tactical discipline neutralized Brazil’s midfield for long stretches, and the equalizer came from individual brilliance rather than systemic pressure. Ancelotti’s side look capable of moments of genius but vulnerable to well-organized opposition — a problem that tends to surface in knockout rounds.
Scotland’s 1-0 win over Haiti was far from fluent, but 20-year-old Ben Gannon-Doak was the tournament’s first breakout performer. The 20-year-old who stole the show on Scotland’s World Cup return The Bournemouth winger, not yet born when Scotland last appeared at a World Cup, carried the ball with a directness and confidence that unsettled Haiti repeatedly. His emergence revives a tradition of tricky Scottish wide players and gives Clarke a genuine attacking weapon for the tougher group games against Morocco and Brazil ahead.
One Thing Worth Reading Deeply
The Researcher Who Didn’t Want to Know
Nancy Wexler spent decades leading the science that produced a genetic test for Huntington’s disease — the condition that killed her mother — yet chose never to take the test herself. Gina Kolata’s portrait holds its central tension without resolving it, which is the point: Wexler’s decision was not inconsistency or denial but a deeply considered refusal to let a probability define a life. The piece doubles as a meditation on what genetic foreknowledge actually gives us, and what it costs, at a moment when base-editing of embryos has reignited exactly those questions.